+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-VEGF Treatments Drugs for Wet AMD Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 85 Pages
  • January 2025
  • Region: Global
  • Prof Research
  • ID: 5726233
Description Jump to:
The treatment landscape for Wet Age-related Macular Degeneration (AMD) has been significantly transformed by the introduction of Anti-VEGF (Vascular Endothelial Growth Factor) therapies. These therapies are designed to inhibit the effects of VEGF, a key growth factor involved in the pathogenesis of Wet AMD, which leads to choroidal neovascularization and subsequent vision loss. By targeting VEGF, Anti-VEGF agents have become the cornerstone for managing Wet AMD, enabling millions of patients to preserve and regain sight.

Market Size, Share, & Trends Analysis

As of 2023, the global market for Anti-VEGF treatments for Wet AMD is estimated to be valued at approximately $7 billion. It is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2025 to 2030. This growth is driven by the rising prevalence of AMD due to an aging population, advancements in drug formulations, and increasing adoption of innovative therapies.

Market Segmentation by Product Type

The Anti-VEGF market can be segmented based on product types, which include:
  • Aflibercept
  • Ranibizumab
  • Bevacizumab
  • Dexamethasone
  • Lucrinolone Acetonide
  • Others

Key Players

The market is characterized by the presence of several key players, including:
  • Novartis AG
  • Regeneron Pharmaceuticals/Bayer
  • Genentech/Roche
  • Allergan
  • Alimera Sciences Inc.
  • Chengdu Kanghong Pharmaceutical Group

Market Analysis by Application and End-Use

The Anti-VEGF treatments find application in various settings, including:
  • Ophthalmology clinics
  • Hospitals
  • Ambulatory surgical centers
In terms of end-use, the primary segments include:
  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

Regional Market Trends

The Anti-VEGF market for Wet AMD shows significant regional variations. Key regions include:
  • North America: Currently leads the market due to high healthcare spending and the presence of major players.
  • Europe: Expected to maintain steady growth owing to a favorable regulatory environment.
  • Asia-Pacific: Emerging as a lucrative market due to rising awareness and improving healthcare infrastructure.
  • Latin America and Middle East & Africa: Expected to witness growth due to increasing incidences of AMD.

Policy News and Market Dynamics

The market for Anti-VEGF therapies is significantly influenced by regulations, reimbursement policies, and approvals by health authorities such as the FDA and EMA. For example, the approval of new combination therapies and the exploration of biosimilars are key developments that could reshape the competitive landscape. Regulatory bodies are also focused on ensuring that treatment protocols adapt to evolving scientific evidence to improve patient outcomes.

Segment Forecasts (2025 2030)

Market Forecast by Product Type

The following is a forecast for the Anti-VEGF market segmented by product type from 2025 to 2030:
  • Aflibercept: Anticipated to maintain its market leadership due to its efficacy, projected CAGR of 6%.
  • Ranibizumab: Expected steady demand with a projected CAGR of 4.5%.
  • Bevacizumab: Continued growth driven by off-label use, with a projected CAGR of 5%.
  • Dexamethasone and Lucrinolone Acetonide: Estimated CAGR of 4% and 4.5% respectively.
  • Others: Will see moderate growth in niche segments.

Forecast by Region

  • North America: Predicted to remain dominant, with a CAGR of 5.5%.
  • Europe: Estimated to follow closely with a CAGR of 5%.
  • Asia-Pacific: Expected to exhibit the highest growth rate of 7% due to increasing investments in healthcare.

Conclusion

The Anti-VEGF treatment market for Wet AMD is poised for considerable growth in the coming years, driven by advancements in therapeutic options, increasing patient populations, and supportive market dynamics. The ongoing innovation in treatment strategies and market expansion in developing regions will likely create lucrative opportunities for existing and new players in the market. As the industry evolves, stakeholders should remain vigilant in monitoring emerging trends, regulatory updates, and competitive developments that can impact market positioning and growth trajectories.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Anti-Vegf Treatments Drugs For Wet Amd Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Anti-Vegf Treatments Drugs For Wet Amd Market in North America (2020-2030)
8.1 Anti-Vegf Treatments Drugs For Wet Amd Market Size
8.2 Anti-Vegf Treatments Drugs For Wet Amd Market by End Use
8.3 Competition by Players/Suppliers
8.4 Anti-Vegf Treatments Drugs For Wet Amd Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Anti-Vegf Treatments Drugs For Wet Amd Market in South America (2020-2030)
9.1 Anti-Vegf Treatments Drugs For Wet Amd Market Size
9.2 Anti-Vegf Treatments Drugs For Wet Amd Market by End Use
9.3 Competition by Players/Suppliers
9.4 Anti-Vegf Treatments Drugs For Wet Amd Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Anti-Vegf Treatments Drugs For Wet Amd Market in Asia & Pacific (2020-2030)
10.1 Anti-Vegf Treatments Drugs For Wet Amd Market Size
10.2 Anti-Vegf Treatments Drugs For Wet Amd Market by End Use
10.3 Competition by Players/Suppliers
10.4 Anti-Vegf Treatments Drugs For Wet Amd Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Anti-Vegf Treatments Drugs For Wet Amd Market in Europe (2020-2030)
11.1 Anti-Vegf Treatments Drugs For Wet Amd Market Size
11.2 Anti-Vegf Treatments Drugs For Wet Amd Market by End Use
11.3 Competition by Players/Suppliers
11.4 Anti-Vegf Treatments Drugs For Wet Amd Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Anti-Vegf Treatments Drugs For Wet Amd Market in MEA (2020-2030)
12.1 Anti-Vegf Treatments Drugs For Wet Amd Market Size
12.2 Anti-Vegf Treatments Drugs For Wet Amd Market by End Use
12.3 Competition by Players/Suppliers
12.4 Anti-Vegf Treatments Drugs For Wet Amd Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Anti-Vegf Treatments Drugs For Wet Amd Market (2020-2025)
13.1 Anti-Vegf Treatments Drugs For Wet Amd Market Size
13.2 Anti-Vegf Treatments Drugs For Wet Amd Market by End Use
13.3 Competition by Players/Suppliers
13.4 Anti-Vegf Treatments Drugs For Wet Amd Market Size by Type
Chapter 14 Global Anti-Vegf Treatments Drugs For Wet Amd Market Forecast (2025-2030)
14.1 Anti-Vegf Treatments Drugs For Wet Amd Market Size Forecast
14.2 Anti-Vegf Treatments Drugs For Wet Amd Application Forecast
14.3 Competition by Players/Suppliers
14.4 Anti-Vegf Treatments Drugs For Wet Amd Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Novartis AG
15.1.1 Company Profile
15.1.2 Main Business and Anti-VEGF Treatments Drugs for Wet AMD Information
15.1.3 SWOT Analysis of Novartis AG
15.1.4 Novartis AG Anti-VEGF Treatments Drugs for Wet AMD Revenue, Gross Margin and Market Share (2020-2025)
15.2 Regeneron Pharmaceuticals/Bayer
15.2.1 Company Profile
15.2.2 Main Business and Anti-VEGF Treatments Drugs for Wet AMD Information
15.2.3 SWOT Analysis of Regeneron Pharmaceuticals/Bayer
15.2.4 Regeneron Pharmaceuticals/Bayer Anti-VEGF Treatments Drugs for Wet AMD Revenue, Gross Margin and Market Share (2020-2025)
15.3 Genentech/Roche
15.3.1 Company Profile
15.3.2 Main Business and Anti-VEGF Treatments Drugs for Wet AMD Information
15.3.3 SWOT Analysis of Genentech/Roche
15.3.4 Genentech/Roche Anti-VEGF Treatments Drugs for Wet AMD Revenue, Gross Margin and Market Share (2020-2025)
15.4 Allergan
15.4.1 Company Profile
15.4.2 Main Business and Anti-VEGF Treatments Drugs for Wet AMD Information
15.4.3 SWOT Analysis of Allergan
15.4.4 Allergan Anti-VEGF Treatments Drugs for Wet AMD Revenue, Gross Margin and Market Share (2020-2025)
15.5 Alimera Sciences Inc.
15.5.1 Company Profile
15.5.2 Main Business and Anti-VEGF Treatments Drugs for Wet AMD Information
15.5.3 SWOT Analysis of Alimera Sciences Inc.
15.5.4 Alimera Sciences Inc. Anti-VEGF Treatments Drugs for Wet AMD Revenue, Gross Margin and Market Share (2020-2025)
15.6 Chengdu Kanghong Pharmaceutical Group
15.6.1 Company Profile
15.6.2 Main Business and Anti-VEGF Treatments Drugs for Wet AMD Information
15.6.3 SWOT Analysis of Chengdu Kanghong Pharmaceutical Group
15.6.4 Chengdu Kanghong Pharmaceutical Group Anti-VEGF Treatments Drugs for Wet AMD Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Anti-Vegf Treatments Drugs For Wet Amd Report
Table Data Sources of Anti-Vegf Treatments Drugs For Wet Amd Report
Table Major Assumptions of Anti-Vegf Treatments Drugs For Wet Amd Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Anti-Vegf Treatments Drugs For Wet Amd Picture
Table Anti-Vegf Treatments Drugs For Wet Amd Classification
Table Anti-Vegf Treatments Drugs For Wet Amd Applications
Table Drivers of Anti-Vegf Treatments Drugs For Wet Amd Market
Table Restraints of Anti-Vegf Treatments Drugs For Wet Amd Market
Table Opportunities of Anti-Vegf Treatments Drugs For Wet Amd Market
Table Threats of Anti-Vegf Treatments Drugs For Wet Amd Market
Table COVID-19 Impact For Anti-Vegf Treatments Drugs For Wet Amd Market
Table Raw Materials Suppliers
Table Different Production Methods of Anti-Vegf Treatments Drugs For Wet Amd
Table Cost Structure Analysis of Anti-Vegf Treatments Drugs For Wet Amd
Table Key End Users
Table Latest News of Anti-Vegf Treatments Drugs For Wet Amd Market
Table Merger and Acquisition
Table Planned/Future Project of Anti-Vegf Treatments Drugs For Wet Amd Market
Table Policy of Anti-Vegf Treatments Drugs For Wet Amd Market
Table 2020-2030 North America Anti-Vegf Treatments Drugs For Wet Amd Market Size
Figure 2020-2030 North America Anti-Vegf Treatments Drugs For Wet Amd Market Size and CAGR
Table 2020-2030 North America Anti-Vegf Treatments Drugs For Wet Amd Market Size by Application
Table 2020-2025 North America Anti-Vegf Treatments Drugs For Wet Amd Key Players Revenue
Table 2020-2025 North America Anti-Vegf Treatments Drugs For Wet Amd Key Players Market Share
Table 2020-2030 North America Anti-Vegf Treatments Drugs For Wet Amd Market Size by Type
Table 2020-2030 United States Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Canada Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Mexico Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 South America Anti-Vegf Treatments Drugs For Wet Amd Market Size
Figure 2020-2030 South America Anti-Vegf Treatments Drugs For Wet Amd Market Size and CAGR
Table 2020-2030 South America Anti-Vegf Treatments Drugs For Wet Amd Market Size by Application
Table 2020-2025 South America Anti-Vegf Treatments Drugs For Wet Amd Key Players Revenue
Table 2020-2025 South America Anti-Vegf Treatments Drugs For Wet Amd Key Players Market Share
Table 2020-2030 South America Anti-Vegf Treatments Drugs For Wet Amd Market Size by Type
Table 2020-2030 Brazil Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Argentina Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Chile Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Peru Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Asia & Pacific Anti-Vegf Treatments Drugs For Wet Amd Market Size
Figure 2020-2030 Asia & Pacific Anti-Vegf Treatments Drugs For Wet Amd Market Size and CAGR
Table 2020-2030 Asia & Pacific Anti-Vegf Treatments Drugs For Wet Amd Market Size by Application
Table 2020-2025 Asia & Pacific Anti-Vegf Treatments Drugs For Wet Amd Key Players Revenue
Table 2020-2025 Asia & Pacific Anti-Vegf Treatments Drugs For Wet Amd Key Players Market Share
Table 2020-2030 Asia & Pacific Anti-Vegf Treatments Drugs For Wet Amd Market Size by Type
Table 2020-2030 China Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 India Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Japan Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 South Korea Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Southeast Asia Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Australia Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Europe Anti-Vegf Treatments Drugs For Wet Amd Market Size
Figure 2020-2030 Europe Anti-Vegf Treatments Drugs For Wet Amd Market Size and CAGR
Table 2020-2030 Europe Anti-Vegf Treatments Drugs For Wet Amd Market Size by Application
Table 2020-2025 Europe Anti-Vegf Treatments Drugs For Wet Amd Key Players Revenue
Table 2020-2025 Europe Anti-Vegf Treatments Drugs For Wet Amd Key Players Market Share
Table 2020-2030 Europe Anti-Vegf Treatments Drugs For Wet Amd Market Size by Type
Table 2020-2030 Germany Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 France Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 United Kingdom Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Italy Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Spain Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Belgium Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Netherlands Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Austria Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Poland Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Russia Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 MEA Anti-Vegf Treatments Drugs For Wet Amd Market Size
Figure 2020-2030 MEA Anti-Vegf Treatments Drugs For Wet Amd Market Size and CAGR
Table 2020-2030 MEA Anti-Vegf Treatments Drugs For Wet Amd Market Size by Application
Table 2020-2025 MEA Anti-Vegf Treatments Drugs For Wet Amd Key Players Revenue
Table 2020-2025 MEA Anti-Vegf Treatments Drugs For Wet Amd Key Players Market Share
Table 2020-2030 MEA Anti-Vegf Treatments Drugs For Wet Amd Market Size by Type
Table 2020-2030 Egypt Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Israel Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 South Africa Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Gulf Cooperation Council Countries Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2030 Turkey Anti-Vegf Treatments Drugs For Wet Amd Market Size
Table 2020-2025 Global Anti-Vegf Treatments Drugs For Wet Amd Market Size by Region
Table 2020-2025 Global Anti-Vegf Treatments Drugs For Wet Amd Market Size Share by Region
Table 2020-2025 Global Anti-Vegf Treatments Drugs For Wet Amd Market Size by Application
Table 2020-2025 Global Anti-Vegf Treatments Drugs For Wet Amd Market Share by Application
Table 2020-2025 Global Anti-Vegf Treatments Drugs For Wet Amd Key Vendors Revenue
Figure 2020-2025 Global Anti-Vegf Treatments Drugs For Wet Amd Market Size and Growth Rate
Table 2020-2025 Global Anti-Vegf Treatments Drugs For Wet Amd Key Vendors Market Share
Table 2020-2025 Global Anti-Vegf Treatments Drugs For Wet Amd Market Size by Type
Table 2020-2025 Global Anti-Vegf Treatments Drugs For Wet Amd Market Share by Type
Table 2025-2030 Global Anti-Vegf Treatments Drugs For Wet Amd Market Size by Region
Table 2025-2030 Global Anti-Vegf Treatments Drugs For Wet Amd Market Size Share by Region
Table 2025-2030 Global Anti-Vegf Treatments Drugs For Wet Amd Market Size by Application
Table 2025-2030 Global Anti-Vegf Treatments Drugs For Wet Amd Market Share by Application
Table 2025-2030 Global Anti-Vegf Treatments Drugs For Wet Amd Key Vendors Revenue
Figure 2025-2030 Global Anti-Vegf Treatments Drugs For Wet Amd Market Size and Growth Rate
Table 2025-2030 Global Anti-Vegf Treatments Drugs For Wet Amd Key Vendors Market Share
Table 2025-2030 Global Anti-Vegf Treatments Drugs For Wet Amd Market Size by Type
Table 2025-2030 Anti-Vegf Treatments Drugs For Wet Amd Global Market Share by Type

Companies Mentioned

  • Novartis AG
  • Regeneron Pharmaceuticals/Bayer
  • Genentech/Roche
  • Allergan
  • Alimera Sciences Inc.
  • Chengdu Kanghong Pharmaceutical Group

Related Topics

Related Reports

Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024 - Product Image

Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024

  • Clinical Trials
  • 240 Pages
  • Global
From
Macular Degeneration Pipeline Analysis Report - Product Image

Macular Degeneration Pipeline Analysis Report

  • Report
  • 150 Pages
  • Global
From
Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2025 - Product Image

Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Macular Degeneration Testing and Therapeutics Market - Forecasts from 2024 to 2029 - Product Image

Macular Degeneration Testing and Therapeutics Market - Forecasts from 2024 to 2029

  • Report
  • 100 Pages
  • Global
From
Macular Degeneration Treatment Market Report 2025 - Product Image

Macular Degeneration Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.